Emergent BioSolutions
Emergent BioSolutions Inc., a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1998, the company has established itself as a key provider of specialty pharmaceuticals, particularly in the fields of biodefence and infectious disease. With a focus on developing and manufacturing vaccines and therapeutics, Emergent BioSolutions is renowned for its unique capabilities in addressing public health threats.
The company operates major facilities across the US and has expanded its reach internationally, contributing to its strong market position. Notable achievements include partnerships with government agencies and a commitment to innovation in vaccine development. Emergent BioSolutions continues to play a vital role in enhancing global health security through its core products and services, which are designed to meet urgent medical needs.
-12 vs industry average
Emergent BioSolutions’s score of 26 is lower than 41% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Emergent BioSolutions?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Emergent BioSolutions's reported carbon emissions
Emergent BioSolutions, a pharmaceutical preparation manufacturing company headquartered in the US, reported approximately 27.4 million kg CO2e for Scope 1 and 2 emissions in 2024. This represents a decrease from the previous year, with Scope 1 and 2 emissions totalling approximately 35.3 million kg CO2e in 2023 and 40.4 million kg CO2e in 2022. The company's disclosed emissions currently cover Scope 1 and Scope 2. Scope 3 emissions data, specifically for purchased goods and services, is currently missing. Emergent BioSolutions has not disclosed specific reduction targets or commitments to initiatives like the Science Based Targets initiative (SBTi) or the Climate Pledge within the provided data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Emergent BioSolutions’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Emergent BioSolutions yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project